Vital-dye-enhanced multimodal imaging of neoplastic progression in a mouse model of oral carcinogenesis

Abstract. In this longitudinal study, a mouse model of 4-nitroquinoline 1-oxide chemically induced tongue carcinogenesis was used to assess the ability of optical imaging with exogenous and endogenous contrast to detect neoplastic lesions in a heterogeneous mucosal surface. Widefield autofluorescence and fluorescence images of intact 2-NBDG-stained and proflavine-stained tissues were acquired at multiple time points in the carcinogenesis process. Confocal fluorescence images of transverse fresh tissue slices from the same specimens were acquired to investigate how changes in tissue microarchitecture affect widefield fluorescence images of intact tissue. Widefield images were analyzed to develop and evaluate an algorithm to delineate areas of dysplasia and cancer. A classification algorithm for the presence of neoplasia based on the mean fluorescence intensity of 2-NBDG staining and the standard deviation of the fluorescence intensity of proflavine staining was found to separate moderate dysplasia, severe dysplasia, and cancer from non-neoplastic regions of interest with 91% sensitivity and specificity. Results suggest this combination of noninvasive optical imaging modalities can be used in vivo to discriminate non-neoplastic from neoplastic tissue in this model with the potential to translate this technology to the clinic.

[1]  S. Tickoo,et al.  Oral Cavity and Esophageal Carcinogenesis Modeled in Carcinogen-Treated Mice , 2004, Clinical Cancer Research.

[2]  Hideaki Matsuoka,et al.  A real-time method of imaging glucose uptake in single, living mammalian cells , 2007, Nature Protocols.

[3]  Timothy J. Muldoon,et al.  Molecular imaging of glucose uptake in oral neoplasia following topical application of fluorescently labeled deoxy‐glucose , 2009, International Journal of Cancer.

[4]  C. MacAulay,et al.  Tracing the “At-Risk” Oral Mucosa Field with Autofluorescence: Steps Toward Clinical Impact , 2009, Cancer Prevention Research.

[5]  H. K. Williams.  Molecular pathogenesis of oral squamous carcinoma , 2000, Molecular pathology : MP.

[6]  Paul M Speight,et al.  Update on Oral Epithelial Dysplasia and Progression to Cancer , 2007, Head and neck pathology.

[7]  Noah Bedard,et al.  Emerging Roles for Multimodal Optical Imaging in Early Cancer Detection: A Global Challenge , 2010, Technology in cancer research & treatment.

[8]  Deepak Kanojia,et al.  4-nitroquinoline-1-oxide induced experimental oral carcinogenesis. , 2006, Oral oncology.

[9]  R. Weissleder,et al.  Imaging in the era of molecular oncology , 2008, Nature.

[10]  Vijayashree S. Bhattar,et al.  Accuracy of In Vivo Multimodal Optical Imaging for Detection of Oral Neoplasia , 2012, Cancer Prevention Research.

[11]  D. Sabatini,et al.  Cancer cell metabolism: one hallmark, many faces. , 2012, Cancer discovery.

[12]  Sharmila Anandasabapathy,et al.  Optical molecular imaging for detection of Barrett's-associated neoplasia. , 2011, World journal of gastroenterology.

[13]  R. Hasina,et al.  ABT-510 Is an Effective Chemopreventive Agent in the Mouse 4-Nitroquinoline 1-Oxide Model of Oral Carcinogenesis , 2009, Cancer Prevention Research.

[14]  Sharmila Anandasabapathy,et al.  Vital-dye enhanced fluorescence imaging of GI mucosa: metaplasia, neoplasia, inflammation. , 2012, Gastrointestinal endoscopy.

[15]  R. Pottier,et al.  5-Aminolaevulinic acid (ALA) induced formation of different fluorescent porphyrins: a study of the biosynthesis of porphyrins by bacteria of the human digestive tract. , 2007, Journal of photochemistry and photobiology. B, Biology.

[16]  Michaell A Huber.  Assessment of the VELscope as an adjunctive examination tool. , 2009, Texas dental journal.

[17]  M. Wainwright,et al.  Acridine-a neglected antibacterial chromophore. , 2001, The Journal of antimicrobial chemotherapy.

[18]  Ann M Gillenwater,et al.  Optical molecular imaging of multiple biomarkers of epithelial neoplasia: epidermal growth factor receptor expression and metabolic activity in oral mucosa. , 2012, Translational oncology.

[19]  Rebecca Richards-Kortum,et al.  Understanding the Biological Basis of Autofluorescence Imaging for Oral Cancer Detection: High-Resolution Fluorescence Microscopy in Viable Tissue , 2008, Clinical Cancer Research.

[20]  K. Hunt,et al.  Wide-field imaging of fluorescent deoxy-glucose in ex vivo malignant and normal breast tissue , 2011, Biomedical optics express.

[21]  N D Le,et al.  Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  A. Gillenwater,et al.  Proliferative verrucous leukoplakia: Recognition and differentiation from conventional leukoplakia and mimics , 2014, Head & neck.

[23]  Daniele Zink,et al.  Nuclear structure in cancer cells , 2004, Nature Reviews Cancer.

[24]  P. D. Dios,et al.  Diagnostic clinical aids in oral cancer , 2010 .

[25]  J. Roodenburg,et al.  The status of in vivo autofluorescence spectroscopy and imaging for oral oncology. , 2005, Oral oncology.

[26]  M. Sturek,et al.  Examining glucose transport in single vascular smooth muscle cells with a fluorescent glucose analog. , 1999, Physiological research.

[27]  A. Polglase,et al.  A fluorescence confocal endomicroscope for in vivo microscopy of the upper- and the lower-GI tract. , 2005, Gastrointestinal endoscopy.

[28]  Rebecca Richards-Kortum,et al.  Advances in molecular imaging: targeted optical contrast agents for cancer diagnostics. , 2012, Nanomedicine.

[29]  M. Aslanoglu.  Electrochemical and Spectroscopic Studies of the Interaction of Proflavine with DNA , 2006, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[30]  R. Richards-Kortum,et al.  Objective Detection and Delineation of Oral Neoplasia Using Autofluorescence Imaging , 2009, Cancer Prevention Research.

[31]  J. Bouquot,et al.  Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. , 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[32]  K. Stoltze,et al.  Oral premalignant lesions: is a biopsy reliable? , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[33]  Oliver Stachs,et al.  Rigid confocal endoscopy for in vivo imaging of experimental oral squamous intra-epithelial lesions. , 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[34]  R. Richards-Kortum,et al.  Multispectral optical imaging device for in vivo detection of oral neoplasia. , 2008, Journal of biomedical optics.

[35]  Martin Krapcho,et al.  SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations) , 2012 .

[36]  Joel B Epstein,et al.  Interobserver reliability in the histopathologic diagnosis of oral pre-malignant and malignant lesions. , 2004, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[37]  Vijayashree S. Bhattar,et al.  Prospective evaluation of a portable depth-sensitive optical spectroscopy device to identify oral neoplasia , 2010, Biomedical optics express.

[38]  H. Abé,et al.  Intracellular fate of 2-NBDG, a fluorescent probe for glucose uptake activity, in Escherichia coli cells. , 1996, Bioscience, biotechnology, and biochemistry.